3 Companies Join Forces to Test Personalized ‘Teaching’ Vaccine for Ovarian Cancer
News
TransGene, NEC, and BostonGene have entered a strategic collaboration to test TG4050, an investigational personalized vaccine that aims to treat ovarian and head and neck cancers, according to a press release. TG4050 ... Read more